[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569894":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":88,"collaborators":7,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":7,"eligibilityCriteria":96,"healthyVolunteers":92,"sex":97,"minAge":7,"maxAge":7,"enrollmentInfo":98,"targetDuration":7,"studyType":101,"phases":7,"briefSummary":102,"conditions":103,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Lifetech Scientific (Shenzhen) Co., Ltd.","INDUSTRY",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Shen Yuanyuan","CONTACT","86+18504356312","shenyuanyuan@lifetechmed.com",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Fu Jiaxuan","86 13973207184","fujiaxuan@lifetechmed.com",[19,35,48,62,75],{"facility":20,"status":21,"city":22,"state":7,"zip":7,"country":23,"countryCode":7,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Ankara (Bilkent) City Hospital","RECRUITING","Ankara","Turkey (Türkiye)",{"type":25,"coordinates":26},"Point",[27,28],32.85427,39.91987,{"lat":28,"lon":27},[31,34],{"name":32,"role":11,"phone":7,"phoneExt":7,"email":33},"ECE Ibrahim","dribrahimece@gmail.com",{"name":32,"role":11,"phone":7,"phoneExt":7,"email":7},{"facility":36,"status":21,"city":37,"state":7,"zip":7,"country":23,"countryCode":7,"cosmosGeoPoint":38,"geoPoint":42,"contacts":43},"Gazi Yasargil Woman and Child Hospital","Diyarbakır",{"type":25,"coordinates":39},[40,41],40.21721,37.91363,{"lat":41,"lon":40},[44,47],{"name":45,"role":11,"phone":7,"phoneExt":7,"email":46},"ALDUDAK Bedri","draldudak@hotmail.com",{"name":45,"role":11,"phone":7,"phoneExt":7,"email":7},{"facility":49,"status":50,"city":51,"state":7,"zip":7,"country":23,"countryCode":7,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Gaziantep University Hospital","NOT_YET_RECRUITING","Gaziantep",{"type":25,"coordinates":53},[54,55],37.3825,37.05944,{"lat":55,"lon":54},[58,61],{"name":59,"role":11,"phone":7,"phoneExt":7,"email":60},"BASPINAR Osman","osmanbaspinar@hotmail.com",{"name":59,"role":11,"phone":7,"phoneExt":7,"email":7},{"facility":63,"status":50,"city":64,"state":7,"zip":7,"country":23,"countryCode":7,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"SiyamiErsek Thoracic and Cardiovascular Surgery Training and Research Hospital","Istanbul",{"type":25,"coordinates":66},[67,68],28.94966,41.01384,{"lat":68,"lon":67},[71,74],{"name":72,"role":11,"phone":7,"phoneExt":7,"email":73},"DEMIR Halil Ibrahim","drdemir1@gmail.com",{"name":72,"role":11,"phone":7,"phoneExt":7,"email":7},{"facility":76,"status":21,"city":77,"state":7,"zip":7,"country":23,"countryCode":7,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Tepecik Training and Research Hospital","Izmir",{"type":25,"coordinates":79},[80,81],27.13838,38.41273,{"lat":81,"lon":80},[84,87],{"name":85,"role":11,"phone":7,"phoneExt":7,"email":86},"NARIN Nazmi","nazmi.narin@gmail.com",{"name":85,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":89,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100569894","lifetech-acumark-sizing-balloon-post-market-clinical-follow-up-study-100569894",false,"NCT06700174","Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study","A Multicenter, Prospective, Single-arm, Observational Study","Inclusion Criteria:\n\n1. Patients who have been confirmed with single secundum atrial septal defect (ASD) by echocardiography;\n2. The anatomy of ASD is suitable for percutaneous closure;\n3. Patients are scheduled to perform ASD closure;\n4. Patients or legally authorized representative(s) who are willing and capable of providing informed consent.\n\nExclusion Criteria:\n\n1. Any contraindication for ASD closure;\n2. Patients have ostium primum ASD or coronary sinus ASD;\n3. Patients who are pregnant or breastfeeding;\n4. Patient is currently participating in another clinical trial that has not yet completed its primary endpoint.","ALL",{"count":99,"type":100},100,"ESTIMATED","OBSERVATIONAL","The objective of this PMCF study is to:\n\n* confirm the safety and performance of the AcuMarkTM Sizing Balloon\n* identify previously unknown side-effects\n* monitor the identified side-effects (related to the procedure or to the medical devices)",[104],"Atrial Septal Defect (ASD)","2024-11-19",{"date":107,"type":108},"2024-11-21","ACTUAL",{"date":110,"type":108},"2024-09-24",{"date":112,"type":100},"2025-03-31",{"name":5,"class":6},5]